| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8716584 | Journal de Mycologie Médicale / Journal of Medical Mycology | 2018 | 5 Pages |
Abstract
Identification of causative fungi is necessary before antifungal treatment. Lowest voriconazole MIC promotes its use as 1st line drug. Comparative higher natamycin MIC, especially against Aspergillus species, warns clinician to have MIC in each case of a non-responding fungal corneal ulcer.
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
M.K. Gupta, A. Chandra, P. Prakash, R. Tilak,